222

LUYE PHARMA GROUP LIMITED

No trades
See on Supercharts
Market capitalization
‪9.68 B‬HKD
‪588.53 M‬HKD
‪6.79 B‬HKD
‪1.85 B‬
Beta (1Y)
0.93

About LUYE PHARMA GROUP LIMITED

CEO
Dian Bo Liu
Headquarters
Yantai
Website
Founded
1994
ISIN
BMG570071099
FIGI
BBG006PTKB26
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2186 is 2.61 HKD — it has decreased by 0.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LUYE PHARMA GROUP LIMITED stocks are traded under the ticker 2186.
LUYE PHARMA GROUP LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
2186 stock is 3.14% volatile and has beta coefficient of 0.93. Check out the list of the most volatile stocks — is LUYE PHARMA GROUP LIMITED there?
One year price forecast for LUYE PHARMA GROUP LIMITED has a max estimate of 4.95 HKD and a min estimate of 2.69 HKD.
2186 earnings for the last quarter are 0.04 HKD per share, whereas the estimation was 0.03 HKD resulting in a 35.33% surprise. The estimated earnings for the next quarter are 0.11 HKD per share. See more details about LUYE PHARMA GROUP LIMITED earnings.
LUYE PHARMA GROUP LIMITED revenue for the last quarter amounts to ‪3.14 B‬ HKD despite the estimated figure of ‪3.22 B‬ HKD. In the next quarter revenue is expected to reach ‪3.50 B‬ HKD.
Yes, you can track LUYE PHARMA GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
2186 stock has fallen by 7.12% compared to the previous week, the month change is a 11.22% fall, over the last year LUYE PHARMA GROUP LIMITED has showed a 32.56% decrease.
2186 net income for the last quarter is ‪413.37 M‬ HKD, while the quarter before that showed ‪169.62 M‬ HKD of net income which accounts for 143.71% change. Track more LUYE PHARMA GROUP LIMITED financial stats to get the full picture.
Today LUYE PHARMA GROUP LIMITED has the market capitalization of ‪9.86 B‬, it has decreased by 4.47% over the last week.
LUYE PHARMA GROUP LIMITED dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2186 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUYE PHARMA GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
2186 reached its all-time high on Oct 30, 2014 with the price of 11.54 HKD, and its all-time low was 1.88 HKD and was reached on Oct 28, 2022.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUYE PHARMA GROUP LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUYE PHARMA GROUP LIMITED stock shows the sell signal. See more of LUYE PHARMA GROUP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LUYE PHARMA GROUP LIMITED future price: according to them, 2186 price has a max estimate of 4.95 HKD and a min estimate of 2.69 HKD. Read a more detailed LUYE PHARMA GROUP LIMITED forecast: see what analysts think of LUYE PHARMA GROUP LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUYE PHARMA GROUP LIMITED EBITDA is ‪1.78 B‬ HKD, and current EBITDA margin is 26.37%. See more stats in LUYE PHARMA GROUP LIMITED financial statements.